Document is current
Any future updates will be listed below
-
Authors
Etkin, Amit https://orcid.org/0000-0001-8259-3521
O’Donnell, Patricio https://orcid.org/0000-0001-7788-624X
Ressler, Kerry J. https://orcid.org/0000-0002-5158-1103
Manji, Husseini https://orcid.org/0009-0007-1679-8749
- License Information
-
More Information
Article History
Accepted: 9 July 2026
First Online: 24 August 2026
Ethics
Competing interests: A.E. and P.O. receive salary from Alto Neuroscience. A.E., P.O. and H.M. hold equity in Alto Neuroscience. H.M. holds equity in Johnson & Johnson. He is Scientific Advisory Board member, Board member, strategic adviser and/or consultant (past 5 years) for: Stanley Center, Dana Foundation, Healthy Brains Global Initiative, McLean Hospital, Foundation for OCD, Dolby Family Ventures, Vanna Health, Alto Neuroscience, Noema, Otsuka, Boehringer-Ingelheim, Sanofi, Apollo Therapeutics, Freedom Biosciences, Empyrean, Lundbeck, Psychogenics and Rapport Therapeutics. K.J.R. has performed scientific consultation for Bioxcel, Bionomics, Acer and Jazz Pharma; serves on Scientific Advisory Boards for Sage, Boehringer Ingelheim, Senseye and the Brain Research Foundation; and has received sponsored research support from Alto Neuroscience.
